Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132580) titled 'Preliminary Study on [18F]SSY-P001 PET Imaging of Cerebral Neuroinflammation in Patients with Cerebral Amyloid Angiopathy' on Sept. 15.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Huashan Hospital, Fudan University
Condition:
cerebral amyloid angiopathy(CAA)
Intervention:
Healthy ontrol group:Intravenous injection of [1?F]SSY-P001 imaging agent (approximately 300 MBq, about 8.1 mCi).
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-15
Target Sample Size: Healthy ontrol group:3;cerebral amyloid angiopathy group:6;
Countries ...